These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 31431597)

  • 1. We Built It, But They Are Not Coming: Exploring Deterrents to Consumer Medication Information Use.
    Monkman H; Kushniruk AW; Barnett J; Borycki EM; Sheets D
    Stud Health Technol Inform; 2019 Aug; 265():189-194. PubMed ID: 31431597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Memory, Perceptions, and Preferences of Multimedia Consumer Medication Information: Experimental Performance and Self-Report Study.
    Monkman H; Kushniruk AW; Borycki EM; Sheets DJ; Barnett J
    JMIR Hum Factors; 2020 Dec; 7(4):e15913. PubMed ID: 33258780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Danish and Canadian Consumer Medication Information.
    Monkman H; Nøhr C; Kushniruk AW
    Stud Health Technol Inform; 2017; 241():147-152. PubMed ID: 28809198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumer Medication Information: Similarities and Differences Between Three Canadian Pharmacies.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():238-242. PubMed ID: 28186048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of consumer medical information and oral liquid measuring devices accompanying pediatric prescriptions.
    Wallace LS; Keenum AJ; DeVoe JE
    Acad Pediatr; 2010; 10(4):224-7. PubMed ID: 20605545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All Consumer Medication Information Is Not Created Equal: Implications for Medication Safety.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():233-237. PubMed ID: 28186047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warnings for drug-drug interactions in consumer medication information provided by community pharmacies.
    Panich J; Gooden A; Shirazi FM; Malone DC
    J Am Pharm Assoc (2003); 2019; 59(1):35-42. PubMed ID: 30416068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets.
    Tong V; Raynor DK; Blalock SJ; Aslani P
    Health Expect; 2016 Jun; 19(3):543-56. PubMed ID: 24905668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumers Better Understand and Prefer Simplified Written Drug Information: An Evaluation of 2 Novel Formats Versus the Current CMI.
    Aker J; Beck M; Papay JI; Cantu T; Ellis M; Keravich D; Bibeau K
    Ther Innov Regul Sci; 2013 Jan; 47(1):125-132. PubMed ID: 30227488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability and readability of consumer medical information accompanying prescription medication samples.
    Wallace LS; Keenum AJ; Roskos SE; Blake GH; Colwell ST; Weiss BD
    Patient Educ Couns; 2008 Mar; 70(3):420-5. PubMed ID: 18178363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of consumer medication information dispensed in retail pharmacies.
    Winterstein AG; Linden S; Lee AE; Fernandez EM; Kimberlin CL
    Arch Intern Med; 2010 Aug; 170(15):1317-24. PubMed ID: 20696955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending FDA guidance to include consumer medication information (CMI) delivery on mobile devices.
    Sage A; Blalock SJ; Carpenter D
    Res Social Adm Pharm; 2017; 13(1):209-213. PubMed ID: 26868207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do medication samples jeopardize patient safety?
    Franks AS; Ray SM; Wallace LS; Keenum AJ; Weiss BD
    Ann Pharmacother; 2009 Jan; 43(1):51-6. PubMed ID: 19092144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimedia educational interventions for consumers about prescribed and over-the-counter medications.
    Ciciriello S; Johnston RV; Osborne RH; Wicks I; deKroo T; Clerehan R; O'Neill C; Buchbinder R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008416. PubMed ID: 23633355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer understanding of prescription drug information: an illustration using an antidepressant medication.
    Shiffman S; Gerlach KK; Sembower MA; Rohay JM
    Ann Pharmacother; 2011 Apr; 45(4):452-8. PubMed ID: 21427296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes from a regular medication information programme for consumers with a mental illness.
    Tran N; Castle D
    Australas Psychiatry; 2012 Apr; 20(2):143-7. PubMed ID: 22461659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children's medicine: What do consumers really want to know?
    Crunkhorn C; van Driel M; Nguyen V; McGuire T
    J Paediatr Child Health; 2017 Feb; 53(2):155-162. PubMed ID: 27662261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.